University at Buffalo - The State University of New York
Skip to Content
Stephen                        Edge

Stephen B. Edge MD

Department of Surgery

Professor

Specialty/Research Focus

Oncology; Surgery

 
Professional Summary:

Research and Professional Goals:
1. Clilnical research program: Our work at Roswell Park Cancer Institute focuses on translational research in breast cancer diagnosis and treatment, including collaborations with other clinicians and scientists in biological markers of cancer and cancer progression.
2. Health Services Research: Using a variety of data sources, we are working on methods to define and improve the quality of cancer care. The models used for this work include administrative claims data from regional payers, and multi institutional databases through national consortiums.
3. Clinical activities: We maintain a high volume, multidisciplinary program in breast cancer diagnosis and treatment at Roswell Park Cancer Institute. Teaching, clinical trials and translational research are integrated into this program at all levels.

Education and Training:
  • Residency, University Hospitals of Cleveland, Case Western Reserve Univ. (1986)
  • Fellowship, National Cancer Institute, Surgery Branch, Bethesda (1984)
  • Internship, University Hospitals of Cleveland, Case Western Reserve University Surgery Program, Cleveland (1980)
  • MD, Case Western Reserve University, Cleveland (1979)
  • BA, Tufts University, Medford (1975)
  • Residency, University Hospitals of Cleveland, Case Western Reserve University Surgery Program, Cleveland


Evaluative Studies and Case Reports:
  • Kane JM, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection.. Ann Surg Oncol. 2001; 8(4).
Journal Articles:
  • Fedewa SA, Ward E, Stewart AK, Edge SB. Delays in Adjuvant Chemotherapy Treatment Among Breast Cancer Patients are More Likely in African American and Hispanic Populations: A National Cohort Study 2004-2006.. J Clin Oncol. 2010.
  • Brasky TM, Bonner MR, Moysich KB, Ochs-Balcom HM, Marian C, Ambrosone CB, Nie J, Tao MH, Edge SB, Trevisan M, Shields PG, Freudenheim JL. Genetic Variants in COX-2 Non-Steroidal Anti-Imflammatory Drugs and Breast Cancer Risk: The Western New York Exposures and Breast Cancer (WEB) Study.. Breast Cancer Res Treat.. 2010.
  • Mandelblatt JS, Sheppard VS, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen JH, Muss H. Breast Cancer Adjuvant Chemotherapy Decisions in Older Women: The Role of Patient Preference and Interactions with Physicians.. J Clin Oncol.. 2010.
  • Brasky TM, Bonner MR, Moysich KB, Amborosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL. Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Breast Cancer Risk in the Western New York Exposures and Breast Cancer (WEB) Study.. Cancer Causes Control. 2010.
  • Edge SB. "Help the Doctor" - Information Systems to Improve Cancer Care in the 21st Century. Journal of Oncology Practice. 2010.
  • Edge SB, Comptom C. Cancer Staging Revisions for the 7th Edition AJCC Cancer Staging Manual.. Ann Surg Oncol. 2010; 17(6).
  • Platek ME, Shields PG, Tan D, Marian C, Bonner MR, McCann SE, Nie J, Wilding GE, Ambrosone C, Millen AE, Trevisan M, Russell M, Nochajski TH, Edge SB, Winston J, Freudenheim JL. Alcohol Consumption and Breast Tumor Mitochondrial DNA Mutations.. Breast Cancer Res Treat. 2010; 121(2).
  • McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosonee, Edge SB, Li HG, Kasprzak C, Freudenheim JL. Dietary Lignan Intakes in Relation to Survival Among Women with Breast Cancer: The Western New York Exposures and Breast Cancer (WEB) Study.. Breast Cancer Res Treat. 2010; 122(1).
  • Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, Wong YN, Weeks JC, Niland JC, Edge SB. The Impact of Breast Reconstruction on the Delivery of Chemotherapy.. Cancer. 2010; 116.
  • Meguerditchian AN, Stewart A, Roistacher J, Watroba N, Cropp M, Edge SB. Claims Data Linked to Hospital Registry Data Enhance Evaluation of the Quality of Care of Breast Cancer.. Journal of Surgica Oncology. 2010; 101(7).
  • Garber JE, Halbai S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge SB, Shapiro CL, Dressler L, Paskett EM, Kimick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N. Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer.. J Natl Cancer Inst.. 2010; 102(13).
  • Edge SB. "Help the Doctor" - The Cultural Shift to 21st Century Care Management.. J Oncol Pract.. 2010; 6(2).
  • Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Epidemiology and End Results-Medicare Data.. Cancer. 2009; 115.
  • Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB. ACR Appropriateness Criteria on Postmastectomy Radiotherapy Expert Panel on Radiation Oncology-Breast.. Int J Radiat Oncol Biol Phys.. 2009; 73(4).
  • Tao MH, Shields PG, Nie J, Marian C, Ambrosone B, McCann SE, Platek, Krishnan SS, Xie B, Edge SB, Winston J, Vito D, Treisan M, Freudenheim JL. DNA Promoter Methylation in Breast Tumors: No Association with Genetic Polymorphisms in MTHFR and MTR.. Cancer Epidemiol Biomarkers Prev.. 2009; 18.
  • Tao MH, Shields PG, Nie J, Millen A, Ambrosone DB, Edge SB, Krishnan SS, Marian C, Xie B, Winston J, Vito D, Trevisan M, Freudenheim JL. DNA Hypermethylation and Clinicopathological Features in Breast Cancer; The Western New York Exposures and Cancer (WEB) Study.. Breast Cancer Res Treat. 2009; 114.
  • Lehman CD, MeMartini W, Anderson BO, Edge SB. Indications for Breast MRI in the Patient with Newly Diagnosed Breast Cancer.. J Natl Compr Netw.. 2009; 7.
  • Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC. NCCN Breast Cancer Clinical Practice Guidelines Panel. Breast Cancer. Clinical Practice Guidelines in Oncology.. J Natl Compr Canc Netw.. 2009; 7.
  • Svahn TH, Niland JC, Carlson RW, Hughes ME, Ottesen RA, Theriault RL, Edge SB, Schott AF, Bookman MA, Weeks JC. Predictors and Temporal Trends of Adjuvant Aromatase Inhibitor Use in Breast Cancer.. J Natl Compr Canc Netw. 2009; 7.
  • McLaughlin CC, Lillquist PP, Edge SB. Surveillance of Prophylactic Mastectomy: Trends in Use from 1995-2005.. Cancer. 2009; 115(23).
  • Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Bown A, Hammond ME, Iglehart JD, Moench Sq, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.. J Natl Comp Cancer Network. 2009; 7.
  • Edge SB. Nipple-Sparing Mastectomy: How Often is the Nipple Involved?. J Clin Oncol. 2009; 27(30).
  • Platek ME, Shields PG, Marian C, McCann SE, Bonner MR, Nie J, Ambrosone CB, Millen AE, Ochs-Balcom HM, Quick DK, Trevisan M, Russell M, Nochajski TH, Edge SB, Freudenheim JL. Alcohol Consumption and Genetic Variation in Methylenetetrahydrofolate Reductase and 5-Methyltetrahyrofolate-Homocysteine Methyltransferase in Relation to Breast Cancer Risk.. Cancer Eipdemiol Biomarkers. 2009; 18(9).
  • Punglia RS, Hughes ME, Edge SB, Theriault RL, Bookman MA, Wilson JL, Ottesen RA, Niland JC, Weeks JC. Factors Associated with Guideline-Concordant Use of Radiation Therapy After Mastectomy in the National Comprehensive Cancer Network.. Int J Radiat Oncol Biol Phys. 2008; 72.
  • Edge SB. Early Adoption and Disturbing Disparities in Sentinel Node Biopsy in Breast Cancer.. J Natl Cancer Inst.. 2008; 100(7).
  • White JR, Halberg FE, Rabinovitch R, Green S, Haffty BG, Solin LJ, Strom EA, Taylor ME, Edge SB. American College of Radiology Appropriateness Criteria on Conservative Surgery and Radiation: Stages I and II Breast Carcinoma.. J Am Coll Radiol.. 2008; 5(6).
  • Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk.. Cancer Epidemiol Biomarkers Prev.. 2008; 17(5).
  • Wong SL, McCahill LE, Edge SB, Askew RL, Beitsch PD, Kollmorgen DR, Anthony T, Petrelli NJ, Cormier JN. Getter to Better Cancer Care: Results of a Society of Surgical Oncology Survey.. Ann Surg Oncol.. 2008; 15(9).
  • Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting High Priority Quality Measures for Breast Cancer Quality Improvement.. Medical Care. 2008; 46(8).
  • Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, Donaldson MS, Kahn KL, Weeks JC, Ko CY, Stewart AK, Edge SB. The ASCO/NCCN Quality Measures.. J Clin Oncol. 2008; 26(21).
  • Hassett JM, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy Use for Hormone Receptor-Positive Lymph Node-Negative Breast Cancer.. J Clin Oncol. 2008; 26.
  • Podoloff DA, Advani RH, Allred AC, Edge SB, et.at.. NCCN Task Force Report: Positron Emission Tomography (PET) Computed Tomography (CT) Scanning in Cancer.. J Natl Compr Canc Netw. 2007.
  • Carlson RW, Anderson BO, Burstein HJ, Edge SB, Et al.. Invasive Breast Cancer (NCCN Guidelines).. J Natl Compr Canc Netw. 2007; 5(2).
  • Eberl MM, Watroba N, Reinhardt M, Pomerantz J, Serghany J, Grovman G, Fox Ch, Mahoney MC, Edge SB. Linked Claims and Medical Records for Cancer Case Management: Evaluation of Mammography Abnormalities.. Cancer. 2007; 110.
  • Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Therialt RL, Weeks JC. Impact of Randomized Clinicl Trial Results on the Use of Tamoxifen Following Breast Surgery for Ductal Carcinoma in Situ in the National Comprehensive Cancer Network.. Journal of Clinical Oncology.. 2007; 25(22).
  • Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. Exposure to Traffic Emmisions Throughout Life and Risk of Breast Cancer. The Western New York Exposures and Breast Cancer (WEB) Study.. Cancer Causes Controls. 2007; 18(9).
  • Varadarajan R, Edge SB, Yu J, Watroba N, Janarthanan BR. Prognosis of Occult Breast Carcinoma Presenting as Isolated Axillary Metastases.. Oncology. 2007; 71(5-6).
  • Fernando SA, Edge SB. Evidence and Controversies in the Use of Post-Mastectomy Radiation.. Journal of the National Comprehensive Cancer Network. 2007; 5.
  • McCann SE, McCann WE, Hong CC, Marshall JR, Edge SB, Trevisan M, Muti P, Freudenheim JL. Dietary Patterns Related to Glycemic Index and Load and Risk of Pre-And-Postmenopausal Breast Cancer in the Western New York Exposures and Breast Cancer (WEB) Study.. American Journal of Clinical Nutrition. 2007; 86(2).
  • Palesty JA, Foster JM, Hurd TC, Watroba N, Rezaishiraz H, Edge SB. Axillary Recurrence In Women with a Negative Sentinel Lymph Node and No Axillary Dissection in Breast Cancer.. J Surg Oncol.. 2006; 93(2).
  • Christian CK, Niland J, Edge SB, Ottesen RA, Hughes ME, Theriault R, Wilson J, Hergrueter CA, Weeks JC. A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction: A Study of the National Comprehensive Cancer Network. Ann Surg. 2006; 243(2).
  • McCann SE, Kulkanri W, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. Dietary Lignan Intakes and Risk of Breast Cancer by Estrogen Receptor Status.. Breast Cancer Research and Treatment.. 2006; 99(3).
  • Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, Bookman MA, Weeks JC. The Use of Radiation as a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers.. J Clin Oncol.. 2006; 24(3).
  • Stoler DL, Bartos JD, wede H, Edge SB, Winston JS, Wiseman SM, Anderson GR. GENOMIC Instability in Invasive Breast Carcinoma Measured by Inter-Simple Sequence Repeat PCR.. Breast Cancer Res Treat. 2006; 97(1).
  • Bonner MR, Han D, Nie J, Rogerson R, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. Breast Cancer Risk and Exposure in Early Life to Polycyclic Aromatic Hydrocarbons Using Total Suspended Particulates as a Proxy Measure.. Cancer Epidemiol Biomarkers Prev.. 2005; 14(1).
  • Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KL, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR. American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-Positive.. Breast Cancer: Status Report 2004. 2005; 23(3).
  • Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL. Secondhand Smoke Exposure in Early Life and the Risk of Breast Cancer Among Never Smokers (US).. Cancer Causes Control. 2005; 16(6).
  • Carlson RW, Anderson BO, Burstein HJ, Cox CE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis C, Jahanzeb M, Ljung BM, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC. National Comprehensive Cancer Network. Breast Cancer.. Journal of Natl Conr Cnc Netw. 2005; 3(3).
  • Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein JH, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer.. Journal of Clinical Oncology. 2005; 23(30).
  • McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. Dietary Lignan Intake and Risk of Pre- And Postmenopausal Breast Cancer.. Int J Cancer. 2004; 111(3).
  • McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL. Dietary Intake of Conjugated Linoleic Acids and Risk of Premenopausal and Postmenopausal Breast Cancer, Western New York Exposures and Breast Cancer Study (WEB Study).. Cancer Epidemiol Biomarkers Prev.. 2004; 13(9).
  • Hinrichs CS, Gibbs JF, Driscoll D, Kepner J, Wilkinson NW, Edge SB, Fassl KA, Muir R, Kraybill WG. The Effectiveness of Complete Decongestive Physiotherapy for the Treatment of Lymphedema Following Groin Dissection for Melanoma.. J Surg Onc. 2004; 85(4).
  • Hinrichs CS, Watroba JL, Hurd TC, Rezaishiraz H, Giese W, Edge SB. Lymphedema Secondary to Postmastectomy Radiation: Incidence and Risk Factors.. Ann Surg Onc. 2004; 11(6).
  • Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. Geographic Clustering of Residence in Early Life and Subsequent Risk of Breast Cancer (USA). Cancer Causes Control. 2004; 15(9).
  • Winer EP, Hudis C, Burstein JH, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, BralowJ, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting.. J Clin Oncol. 2003; 21.
  • Stomper P, Geradts J, Edge SB, Levine E. Mammographic Predictors of the Presence and Size of Invasive Carcinomas Associated With Malignant Microcalcification Lesions Without a Mass.. AJR Am J Roent. 2003; 181.
  • Christian CK, Edge SB, Niland J, Ottesen R, Hughes M, Wilson J, Hergrueter C, Weeks JC. A Multi-Institutional Analysis of the Socioeconomic Determinants of Breast Reconstruction.. J Surg Res. 2003; 114(2).
  • Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Gutierriz-Romero M, Brooks JSJ, Michalek AM. Variation of the Prognostic Significance of HER2 Expression in Breast Cancer According to Tumor Size.. The Breast Journal. 2003; 9(2).
  • Edge SB, Sheldon DG. Sentinel Node Biopsy is Not Indicated in Ductal Carcinoma in Situ.. J Natl Comp Cancer Network. 2003; 1.
  • Charles M, Edge SB, Winston JS, Hurd TC, Driscoll DL, Stomper PC. The Effect of Stereotactic Core Needle Biopsy on Pathologic Measurement of Tumor Size of T1Invasive Breast Cancers Presenting as Mammographic Masses.. Cancer. 2003; 97.
  • Lamonica D, Edge S, Hurd TC, Proulx G, Stomper PC. Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures.. Clinical Nuclear Medicine. 2003; 28(7).
  • Edge S, Niland J, Bookman M, Thieriault R, Ottesen R, Lepisto E, Weeks JC. Adoption of sentinel lymph node biopsy as a component of standard care for breast cancer in comprehensive cancer centers. Provisionally accepted.. J Natl Cancer Inst.. 2003; 95.
  • Winer EP, Hudis C, Harold J, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles, Whelan TJ, Browman GP. American Society of Clinical Oncology Trechnology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women with Hormone Receptor Positive Breast Cancer: Status Report 2002.. J Clin Oncol.. 2002; 20.
  • Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Zhong A, Hwang YT, Weeks JC. Sequelae of Axillary Node Dissection in Older Women with Stage 1 and !! Breast Cancer.. Cancer. 2002; 95(12).
  • Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB. Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition.. Am J Clin Oncol. 2001; 24(4).
  • Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma.. J Surg Oncol. 2001; 77(4).
  • Mandelblatt JS, Berg CD, Meropol NJ, Edge SB, Gold K, Hwang YT, Hadley J. Measuring and predicting surgeons‘ practice styles for breast cancer treatment in older women.. Med Care. 2001; 39(3).
  • Khatri VP, Hurd T, Edge SB. Simple technique of early identification of the thoracodorsal nerve during axillary dissection.. J Surg Oncol. 2001; 76(2).
  • Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Downregulation of gelsolin correlates with the progression to breast carcinoma.. Breast Cancer Res Treat. 2001; 65(1).
  • Edge SB, Pisters PWT. Defining Core Information for the Training and Continuing Education of Surgical Oncologists (editorial).. Annals of Surgical Oncology. 2001; 8(7).
  • Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. Accuracy of Sentinel Node Metastases in Predicting the Nodal Status in Patients with Breast Carcinoma.. J Surg Onc. 2001; 77.
  • Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Breast Cancer Risk Factors and HER-2 Overexpression in Tumors.. Cancer. 2001; 25(6).
  • Carlson RW, Edge SB, Theriault R. National Comprehensive Cancer Network 6th Annual Conference Proceedings: Breast Cancer.. Cancer Control. 2001; 8(6).
  • Khatri VP, Hurd TC, Edge SB. Simple Technique of Early Identification of the Thoracolorsal Nerve During Axillary Dissection.. Journal of Surgical Oncology. 2001; 76.
  • Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook S, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW, Jr., Whelan TJ. Postmastectomy Radiotherapy Guidelines of the American Society of Clinical Oncology.. Journal of Clinical Oncology. 2001; 19.
  • Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. Altered expression and localization of PKC eta in human breast tumors.. Breast Cancer Research and Treatment. 2001; 68.
  • Waddell BE, Stomper PC, DeFazio JL, Hurd TC, Edge SB. Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast.. Ann Surg Oncol. 2000; 7(9).
  • Xu Y, Edge S, Hurd T, Repasky E, Slocum HK. Implantation and Characterization of Human Breast Carcinomas in SCID Mice. Methods in Mammary Gland Biology and Breast Cancer Research.. Ip M and Asch M, eic. Kluwer Academic. 2000.
  • Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GN, Ruby SC, O‘Malley F, Sipson FJ, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ. Prognostic Factors in Breast Cancer: College of American Pathologist Consensus Statement 1999.. Archives Pathol Lab Med. 2000; 124.
  • Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffeth J, Edge SB, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R. Patterns of Breast Cancer Treatment in Older Women: Patient Preference and Clinical and Physician Influence.. Cancer. 2000; 89.
  • Carlson RW, Anderson BO, Bensinger W, Cox CE, Davidson NE, Edge SB, Farrar WB, Goldstein LF, Gradishar WJ, Lichter AS, McCormick B, Nabell LM, Reed ED, Silver SM, Smith ML, Somlo G, Theriault R, Ward JH, Winer EP, Wolff A. NCCN Practice Guidelines for Breast Cancer.. Oncology. 2000; 14(11A).
  • Waddell B, Stomper P, Hurd TC, Edge SB. Post-Excision Mammography is Indicated After Resection of Ductal Carcinoma in Situ.. Annals of Surgical Oncology. 2000; 7(9).
  • Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.. Breast Cancer Res Treat. 1999; 55(2).
  • Edge SB, Hurd TC. Sentinel Node Update: Breast Cancer.. Oncology. 1999; 13(11A).
  • Asch HL, Winston JS, Edge SB, Stomper P, Asch B. Down-Regulation of Gelsolin Expression in Human Breast Ductal Carcinoma With and Without Invasion.. Breast Cancer Research and Treatment. 1999; 55.
  • Stomper PC, Waddell BE, Edge SB, Klippenstein DL. Breast MRI in the Evaluation of Patients With Occult Primary Breast Carcinoma.. The Breast Journal. 1999; 5(4).
  • Yarussi A, Sands R, Edge SB, Lema MJ, DeLeon-Casasola OA. Evaluation of Peripheral Morphine Analgesia for Lumpectomy and Axillary Node Dissection: A Randomized, Double-Blinded Placebo-Controlled Study.. Regional Anesthesia and Pain Medicine. 1999; 24(2).
  • Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, Zhang P, Winston J, Edge SB. Sentinel node biopsy in breast cancer.. Ann Surg Oncol. 1998; 5(2).
  • North JH, McPhee M, Arredondo M, Edge SB. Sarcoma of the Breast: Implications of the Extent of Local Therapy.. American Surgeon. 1998; 64.
  • Kollmorgen DR, Varanasi JS, Edge SB, Carson WE. Paget's Disease of the Breast: A 33 Year Experience.. Journal of the American College of Surgeons. 1998; 187.
  • Zhang PJ, Reisner RM, Nangia R, Edge SB, Brooks JJ. Effectiveness of Multiple-Level Sectioning in Detecting Axillary Nodal Metastases in Breast Cancer. A Retrospective Study with Immunohistochemical Analysis.. Archives of Pathology and Laboratory Medicine. 1998; 122.
  • Beitler AL, Hurd TC, Edge SB. The evaluation of palpable breast masses: common pitfalls and management guidelines.. Surg Oncol. 1997; 6(4).
  • Edge SB. Breast Cancer Practice Guidelines: Evaluation and Quality Improvement.. Oncology. 1997; 11(11a).
  • Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE. Suspect Breast Lesions: Findings at Dynamic Gadolinium-Enhanced MR Imaging Correlated With Mammographic and Pathologic Features.. Radiology. 1996; 197.
  • Sakakibara T, Xu Y, Bumpers HL, Chen FA, Bankert RB, Arredondo MA, Edge SB, Repasky EA. Growth and Metastasis of Surgical Speciments of Human Breast Carcinomas in SCID Mice.. the Cancer Journal from Scientific American. 1996; 2.
  • Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC. Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.. Breast Cancer Res Treat. 1996; 37(3).
  • Cuenca RE, Giachina J, Arredondo AM, Hempling R, Edge SB. Endometrial Cancer Associated with Breast Cancer: Low Incidence with Tamoxifen Use.. Cancer. 1996; 77.
  • McPhee M, Edge SB, Loree T. Breast Cancer After Breast Augmentation.. Current Problems in General Surgery. 1996; 13(1).
  • Green DM, Edge SB, Penetrante RB, Bakshi S, Shedd D, Zevon MA. In situ breast carcinoma after treatment during adolescence for thyroid cancer with radioiodine.. Med Pediatr Oncol. 1995; 24(2).
  • Bauer RL, Busch E, Levine E, Edge SB. Therapy of Inflammatory Breast Cancer; Impact of Doxorubicin-based Therapy.. Annals of Surgical Oncology. 1995; 2(4).
  • Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Tsangaris TN, Edge SB. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.. Ann Surg Oncol. 1994; 1(2).
  • Carson W, Sanchez-Forgach E, Stomper P, Penetrante R, Edge SB. Management of Lobular Carcinoma In Ssitu: Observation Without Surgery as an Appropriate Therapy.. Annals of Surgical Oncology. 1994; 1(2).
  • Edge SB, Schmieg RE, Rosenlof LK, Wilhelm MC. Pancreas Cancer Resections in American University Center: Outcome for 223 Resections in 1989-1990.. Cancer. 1993; 71.
  • Schirmer BD, Schmeig RE Jr., Dix J, Edge SB, Hanks JB. Laparoscopic Versus Traditional Appendectomy for Suspected Appendicitis.. American Journal of Surgery. 1993; 165.
  • Spaulding CA, DeParades ES, Anne P, Edge SB, Wilhelm MC. Detection of Recurrence After Breast Conservation Treatment with Radiotherapy.. Breast Disease. 1992; 158.
  • DeLange EE, Fechner RE, Spaulding CA, Edge SB. MrI Evaluation of Rectal Cancer Response to Preoperative Radiation Therapy.. American Journal of Radiology. 1992; 158.
  • Schirmer BD, Dix J, Edge SB, Hyser MJ, Hank JM, Aguilar M. Laparoscopic Cholecystectomy in the Obese Patient.. Annals of Surgery. 1992; 216(2).
  • McKinney CD, Frierson HF, Fechner RE, Wilhelm MC, Edge SB. Pathologic findings in Nonpalpable Invasive Breast Cancer.. American Journal of Surgical Pathology. 1992; 16.
  • Schirmer BC, Edge SB, Dix J, Miller A. Incorporation of Laparoscopy Into a Residency Training Program.. American Journal of Surgery. 1992; 163.
  • Wilhelm MC, Edge SB, Cole DD, DeParades E, Frierson HR Jr.. Non-Palpable Invasive Breast Cancer.. Annals of Surgery. 1991; 213.
  • Schirmer BD, Edge SB, Dix J, Hyser MJ, Hanks JB, Jones RS. Laparoscopic Cholecystectomy is the Treatment of Choice for Symptomatic Cholelithiasis.. Annals of Surgery. 1991; 213.
  • DeLange EE, Fechner RE, Edge SB, Spaulding CA. Preoperative Staging of Rectal Cancer with MR Imaging: Surgical and Histopathologic Correlation.. Radiology. 1990; 176.
  • Edge SB, Schirmer BD, Dix J. A New Technique for Gallstones: Laparoscopic Cholecystectomy at UVA. Virginia Medical Quarterly. 1990; 117.
  • Edge SB, Funkhouser WK, Berman A, Seipp C, Tanner A, Wesley R, Rosenberg SA, Chang AE. High Dose Oral and Intravenous Metoclopramide in Doxorubicin/Cyclophosphamide Induced Emesis: A Randomized Double Blind Study.. American Journal of Clinical Oncology. 1987; 10.
  • Edge SB, Hoeg JM, Triche T, Schneider PD, Brewer HB, Jr.. Cultured Human Hepatocytes: Evidence for Metabolism of Low Density Lipoproteins by a Pathway Independent of the Classical Low Density Lipoprotein Receptor.. Journal of Biological Chemistry. 1986; 261.
  • Edge SB, Hoeg JM, Schneider PD, Brewer HB Jr.. Apolipoprotein B Synthesis in Humans: Liver Synthesizes Only Apolipoprotein B-100.. Metabolism. 1985; 34.
  • Hoeg JM, Edge SB, Demosky SJ, Jr., Starzl TE, Triche T, Gregg RE, Brewer HB, Jr.. Metabolism of Low Density Lipoproteins by Cultured Hepatocytes from Normal and Homozygous Familial Hypercholesterolemic Subjects.. Biochem Biophys Acta. 1985; 876.
  • Lackner KJ, Edge SB, Gregg RE, Hoeg JM, Brewer HB, Jr.. Isoforms of Apolipoprotein A-11 In Human Plasma and Thoracic Duct Lymph: Identification of Proapolipoprotein A-11 and Sialic Acid-Containing Isoforms.. Journal of Biological Chemistry. 1985; 260.
  • Hoeg JM, Demosky SJ, Jr., Edge SB, Gregg RE, Osborne JC, Brewer HB, Jr.. Characterization of a Human Hepatic Receptor for High Density Lipoproteins.. Arteriosclerosis. 1985; 5.
  • Edge SB, Gorschboth C, Schneider PD. Selective Inhibition of Tumor Cell Growth by Sterol Synthesis Inhibition.. Surgical Forum. 1982; 33.
  • Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Breast cancer risk factors and HER2 over-expression in tumors.. Cancer Detect Prev. ; 25(6).
See all (111 more)
Abstracts:
  • Wilkinson NW, Shahryarinejad A, Winston JS, Watroba N, Edge SB. Concordance with breast cancer pathology reporting practice guidelines: Community-wide practice.. Journal of the American College of Surgeons (in press – accepted August, 2002, Elsevier Science Journals Reference Number ACS2106 - anticipated publication December, 2002). 2003; 196.
  • Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL,Thor A, Weaver DL, Wieand HS, Greene FL. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer.. J Clin Oncol 2002. 2002; 20.
  • McKee M, Cropp M, Hyland A, Watroba N, McKinely B, Edge SB. Provider case volume and outcome in the evaluation and treatment of mammogram-detected breast cancer.. Cancer 2002. 2002; 95.
  • Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM, Hwang YT, Mandelblatt JS. Patient and provider characteristics affecting use of axillary dissection in older women with Stage I/II breast cancer.. Cancer 2002. 2002; 94.
  • Proulx GM, Loree T, Edge S, Hurd T, Stomper P. Outcome with post mastectomy radiation with TRAM flap breast reconstruction.. American Surgeon 2002. 2002; 68.
  • Proulx GM, Hurd T, Lee RJ, Stomper PC, Podgorsak MB, Edge SB. Intraoperative radiation therapy (IORT) to the tumor bed only for breast cancer: technique and outcome.. Radiation Oncology 2001. 2001; 35(1).
  • Yates J, Edge SB. Evaluating guidelines: an important step in improving cancer care.. Oncology (Huntingt) 1999. 1999; 13(11A).
  • Edge SB, Fritz A, Clutter GG, Page DL, Watkins S, Blankenship C, Douglas K, Fleming I. A unified cancer stage data collection system: Preliminary report from the Collaborative Stage Task Force / American Joint Committee on Cancer.. Journal of Registry Management 1999. 1999; 26.
  • Yarussi A, Sands R, Edge SB, Lema MJ, deLeon-Casasola OA. Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: A randomized, double-blinded placebo-controlled study.. Regional Anesthesia and Pain Medicine. 1999. ; 24(2).
  • Carlson RW, Anderson BO, Bensinger W, Cox C. Davidson NE, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Lichter AS, McCormick B, Nabell LM, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Winer EP. National Cancer Center Network Breast Cancer Guidelines.. Oncology (Huntington) 1999. ; 13(5A).
  • Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffeth J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R. Patterns of breast cancer treatment in older women - Patient preference and clinical and physician influence.. Cancer 2000. ; 89.
  • Edge SB. Evidence-based breast cancer staging (editorial).. Breast Diseases: A Year Book Quarterly 2001. ; 12.
  • Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Gutierriz-Romero M, Brooks JSJ, Michalek AM. Variation of prognostic significance of HER2 expression in breast cancer according to tumor size.. The Breast Journal (in press – Manuscript #21124)..
  • Mandelblatt JS, Edge SB, Meropol NJ, Senie R, Tsangaris T, Grey L, Peterson B, Zhong A, Hwang YT, Weeks JC. Sequelae of axillary node dissection in older women with localized breast cancer.. Cancer (in press – accepted June, 2002 – Manuscript #C-0628-02)..
  • Winer EP, Hudis C, Harold J. Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles, Whelan TJ, Browman GP. American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women with Hormone Receptor Positive Breast Cancer: Status Report 2002.. J Clin Oncol. 2002. ; 20.
See all (5 more)
Books and Book Chapters:
  • Xu Y, Edge SB, Hurd TC, Repasky E, Slocum HK. Implantation and characterization of human breast carcinomas in SCID mice.. Methods in Mammary Gland Biology and Breast Cancer Research. Ip M and Asch M, eic. Kluwer Academic, New York, 2000..


School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Roswell Park Cancer Institute
Elm & Carlton Streets
Department of Surgery
Buffalo, NY 14263
Phone: (716) 845-2918
Fax: (716) 845-1668
Email: edge@buffalo.edu

Patient Care

Looking for a doctor? This faculty member is affiliated with UBMD, the group comprised of practicing physicians who are also professors in the UB Jacobs School of Medicine and Biomedical Sciences.

View this faculty on UBMD

Log in to Update Your Profile